Allscripts Healthcare Solutions Stock Forecast, Price & News

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

Is Allscripts Healthcare Solutions a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Allscripts Healthcare Solutions stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDRX, but not buy additional shares or sell existing shares.
View analyst ratings for Allscripts Healthcare Solutions or view top-rated stocks.

How has Allscripts Healthcare Solutions' stock price been impacted by Coronavirus (COVID-19)?

Allscripts Healthcare Solutions' stock was trading at $6.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MDRX stock has increased by 177.5% and is now trading at $17.51.
View which stocks have been most impacted by COVID-19.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Allscripts Healthcare Solutions.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) posted its earnings results on Thursday, November, 4th. The software maker reported $0.27 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.18 by $0.09. The software maker earned $369 million during the quarter, compared to analyst estimates of $376.09 million. Allscripts Healthcare Solutions had a trailing twelve-month return on equity of 6.98% and a net margin of 51.74%. The firm's revenue was down 8.2% on a year-over-year basis. During the same quarter last year, the company earned $0.15 EPS.
View Allscripts Healthcare Solutions' earnings history.

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions declared that its Board of Directors has approved a stock buyback program on Wednesday, May 26th 2021, which authorizes the company to buyback $350,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 14% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's management believes its stock is undervalued.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions issued an update on its FY 2021 earnings guidance on Thursday, December, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.50 billion-$1.50 billion, compared to the consensus revenue estimate of $1.50 billion.

What price target have analysts set for MDRX?

7 brokers have issued twelve-month price objectives for Allscripts Healthcare Solutions' stock. Their forecasts range from $17.00 to $20.00. On average, they anticipate Allscripts Healthcare Solutions' stock price to reach $18.75 in the next twelve months. This suggests a possible upside of 7.1% from the stock's current price.
View analysts' price targets for Allscripts Healthcare Solutions or view top-rated stocks among Wall Street analysts.

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the following people:

• Paul M. Black, Chief Executive Officer & Director (LinkedIn Profile)
• Richard J. Poulton, President & Chief Financial Officer
• Joseph R. Rostock, Chief Technology Officer & Senior VP-Development
• Lisa Khorey, Chief Client Delivery Officer & Executive VP (LinkedIn Profile)
• Eric Jacobson, Secretary & Senior Vice President

What is Paul Black's approval rating as Allscripts Healthcare Solutions' CEO?

796 employees have rated Allscripts Healthcare Solutions CEO Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among Allscripts Healthcare Solutions' employees.

Who are some of Allscripts Healthcare Solutions' key competitors?

Some companies that are related to Allscripts Healthcare Solutions include Cerner (CERN), Omnicell (OMCL), Vocera Communications (VCRA), HealthStream (HSTM), Computer Programs and Systems (CPSI), Athena Technology Acquisition (ATHN), Cortexyme (CRTX) and Mirage Energy (MRGE).
View all of MDRX's competitors.

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a variety of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.05%) and Crossmark Global Holdings Inc. (0.01%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, Paul Black and Richard J Poulton.
View institutional ownership trends for Allscripts Healthcare Solutions.

Which institutional investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., State of Alaska Department of Revenue, and Louisiana State Employees Retirement System. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, Paul Black, and Richard J Poulton.
View insider buying and selling activity for Allscripts Healthcare Solutions or view top insider-selling stocks.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $17.51.

How much money does Allscripts Healthcare Solutions make?

Allscripts Healthcare Solutions has a market capitalization of $2.15 billion and generates $1.50 billion in revenue each year. The software maker earns $700.41 million in net income (profit) each year or $5.15 on an earnings per share basis.

How many employees does Allscripts Healthcare Solutions have?

Allscripts Healthcare Solutions employs 8,400 workers across the globe.

Does Allscripts Healthcare Solutions have any subsidiaries?

The following companies are subsidiares of Allscripts Healthcare Solutions: HealthGrid, Practice Fusion, and ZappRx.

When was Allscripts Healthcare Solutions founded?

Allscripts Healthcare Solutions was founded in 1986.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is www.allscripts.com.

Where are Allscripts Healthcare Solutions' headquarters?

Allscripts Healthcare Solutions is headquartered at 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at (800) 334-8534, via email at [email protected], or via fax at 313-322-9600.